SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Comprehensive Opioid Recovery 
Centers Act of 2018''.

SEC. 2. COMPREHENSIVE OPIOID RECOVERY CENTERS.

    (a) In General.--Part D of title V of the Public Health Service Act 
is amended by adding at the end the following new section:

``SEC. 550. COMPREHENSIVE OPIOID RECOVERY CENTERS.

    ``(a) In General.--The Secretary shall award grants on a 
competitive basis to eligible entities to establish or operate a 
comprehensive opioid recovery center (referred to in this section as a 
`Center').
    ``(b) Grant Period.--
            ``(1) In general.--A grant awarded under subsection (a) 
        shall be for a period not less than 3 years and not more than 5 
        years.
            ``(2) Renewal.--A grant awarded under subsection (a) may be 
        renewed, on a competitive basis, for additional periods of 
        time, as determined by the Secretary. In determining whether to 
        renew a grant under this paragraph, the Secretary shall 
        consider the data submitted under subsection (h).
    ``(c) Minimum Number of Centers.--The Secretary shall allocate the 
amounts made available under subsection (i) in such amounts that not 
fewer than 10 Centers will be established across the United States.
    ``(d) Application.--In order to be eligible for a grant under 
subsection (a), an entity shall submit an application to the Secretary 
at such time and in such manner as the Secretary may require. Such 
application shall include--
            ``(1) evidence that such entity carries out, or is capable 
        of coordinating with other entities to carry out, the 
        activities described in subsection (g); and
            ``(2) such other information as the Secretary may require.
    ``(e) Priority.--In awarding grants under subsection (a), the 
Secretary shall give priority to eligible entities located in a State 
or Indian country (as defined in section 1151 of title 18, United 
States Code)--
            ``(1) with a high per capita drug overdose mortality rate, 
        as determined by the Director of the Centers for Disease 
        Control and Prevention; or
            ``(2) based on any other criteria or need, as determined by 
        the Secretary.
    ``(f) Use of Grant Funds.--An eligible entity awarded a grant under 
subsection (a) shall use the grant funds to establish or operate a 
Center to carry out the activities described in subsection (g).
    ``(g) Center Activities and Services.--Each Center shall, at a 
minimum, carry out the activities described in this subsection. In the 
case of a Center that determines that a service described in paragraph 
(2) cannot reasonably be carried out by the Center, such Center shall 
contract with such other entities as may be necessary to ensure that 
patients have access to the full range of services described in such 
paragraph.
            ``(1) Community outreach.--Each Center shall carry out the 
        following outreach activities:
                    ``(A) Train and supervise outreach staff to work 
                with schools, workplaces, faith-based organizations, 
                State and local health departments, law enforcement, 
                and first responders to ensure that such institutions 
                are aware of the services of the Center.
                    ``(B) Disseminate and make available online 
                evidence-based resources that educate professionals and 
                the public on opioid use disorder and other substance 
                use disorders.
            ``(2) Treatment and recovery services.--Each Center shall 
        provide the following treatment and recovery services:
                    ``(A) Ensure that intake evaluations meet the 
                clinical needs of patients.
                    ``(B) Periodically conduct patient assessments to 
                ensure continued and meaningful recovery, as defined by 
                the Assistant Secretary for Mental Health and Substance 
                Use.
                    ``(C) Provide the full continuum of treatment 
                services, including--
                            ``(i) all drugs approved under section 505 
                        of the Federal Food, Drug, and Cosmetic Act and 
                        all biological products licensed under section 
                        351 of this Act, including methadone, to treat 
                        substance use disorders, including opioid use 
                        disorder and alcohol use disorder;
                            ``(ii) withdrawal management, which shall 
                        include medically supervised detoxification 
                        that includes patient evaluation, 
                        stabilization, and readiness for and entry into 
                        treatment;
                            ``(iii) counseling and case management, 
                        including counseling and recovery services for 
                        any possible co-occurring mental illness;
                            ``(iv) residential rehabilitation;
                            ``(v) recovery housing;
                            ``(vi) community-based and peer recovery 
                        support services;
                            ``(vii) job training and placement 
                        assistance to support reintegration into the 
                        workforce; and
                            ``(viii) other best practices, as 
                        determined by the Secretary.
                    ``(D) Administer an onsite pharmacy and provide 
                toxicology services.
                    ``(E) Establish and operate a secure and 
                confidential electronic health information system.
                    ``(F) Offer family support services such as child 
                care, family counseling, and parenting interventions to 
                help stabilize families impacted by substance use 
                disorder.
    ``(h) Data Reporting and Program Oversight.--With respect to a 
grant awarded under subsection (a) to an eligible entity for a Center, 
not later than 90 days after the end of the first year of the grant 
period, and annually thereafter for the duration of the grant period 
(including the duration of any renewal period for such grant), the 
entity shall submit data, as appropriate, to the Secretary regarding--
            ``(1) the programs and activities funded by the grant;
            ``(2) health outcomes of individuals with a substance use 
        disorder who received services from the Center;
            ``(3) the effectiveness of interventions designed, tested, 
        and evaluated by the Center; and
            ``(4) any other information that the Secretary may require 
        for the purpose of--
                    ``(A) evaluating the effectiveness of the Center; 
                and
                    ``(B) ensuring that the Center is complying with 
                all the requirements of the grant, including providing 
                the full continuum of services described in subsection 
                (g)(2)(C) and providing drugs and devices for overdose 
                reversal under such subsection.
    ``(i) Authorization of Appropriations.--There is authorized to be 
appropriated $10,000,000 for each of fiscal years 2019 through 2023 for 
purposes of carrying out this section.''.
    (b) Reports to Congress.--
            (1) Preliminary report.--Not later than 3 years after the 
        date of the enactment of this Act, the Secretary of Health and 
        Human Services shall submit to Congress a preliminary report 
        that analyzes data submitted under section 550(h) of the Public 
        Health Service Act, as added by subsection (a).
            (2) Final report.--Not later than 1 year after submitting 
        the preliminary report required under paragraph (1), the 
        Secretary of Health and Human Services shall submit to Congress 
        a final report that includes--
                    (A) an evaluation of the effectiveness of 
                comprehensive opioid recovery centers established or 
                operated pursuant to section 550 of the Public Health 
                Service Act, as added by subsection (a);
                    (B) recommendations on whether the grant program 
                established under such section 550 should be 
                reauthorized and expanded; and
                    (C) standards and best practices for the treatment 
                of substance use disorders, as identified through such 
                grant program.

            Passed the House of Representatives June 12, 2018.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
Comprehensive Opioid Recovery Centers Act of 2018 This bill amends the Public Health Service Act to require the Department of Health and Human Services to award grants to establish or operate comprehensive opioid recovery centers. Priority for grants must be given to entities located in states or Indian country with a high per capita drug overdose mortality rate. Each center must carry out specified outreach activities and specified treatment and recovery services.
{"src": "billsum_test", "title": "Comprehensive Opioid Recovery Centers Act of 2018"}